Construction of linker-scanning mutations using the polymerase chain reaction.
Harlow
P P
PP
DuPont Merck Pharmaceutical Company, Wilmington, DE.
Hobson
G M
GM
Benfield
P A
PA
D004274:DNA, Recombinant / Q000235:genetics; D016297:Mutagenesis, Site-Directed; D009841:Oligonucleotides / Q000737:chemistry / Q000235:genetics; D017354:Point Mutation; D016133:Polymerase Chain Reaction / Q000379:methods*; D017384:Sequence Deletion
D004274:DNA, Recombinant; D009841:Oligonucleotides